InflaRx

Biotechnology

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR.

IFRX

Visualizar Fundamentos

InflaRx

0,9

P/B

909,1

P/S

—

P/EBITDA

—

Forward P/E

1,8

BVPS

—

EPS